Introduction {#sec1-1}
============

Many data suggest a relationship between chronic kidney disease and hypothyroidism, most of them subclinical hypothyroidism.\[[@ref1][@ref2][@ref3][@ref4]\] It has been shown in studies that hypothyroidism had a cardiovascular risk and it can increase the mortality in a dialysis patient.\[[@ref5][@ref6][@ref7][@ref8]\]

Some studies indicate that treating hypothyroidism can preserve kidney function in chronic kidney disease.\[[@ref9][@ref10]\] Establishing hypothyroidism diagnosis among chronic kidney disease patients is difficult and depends purely on biochemical parameters. Therefore, reviewing the relationship between hypothyroidism and chronic kidney disease is essential. This challenging question had been tested, and the researchers faced some difficulties like high urea can move the thyroid hormone from its binding protein,\[[@ref10]\] use of heparin can increase free thyroxine,\[[@ref11][@ref12]\] and peritoneal dialysis can remove the thyroxine.\[[@ref13]\]

However, there is no Saudi data regarding the prevalence of hypothyroidism in patients with chronic kidney disease. Therefore, we conducted this survey to establish a database for subsequent studies.

Materials and Methods {#sec1-2}
=====================

We performed a cross-sectional analysis based on the database of the laboratory information system of the clinical chemistry laboratory at security forces hospital to retrieve results of serum creatinine, thyroid-stimulating hormone TSH, free T4, and parathyroid hormone PTH, which have been performed. Outpatient adults (over 18 years of age) followed in nephrology department from January 2015 to February 2018.

Serum TSH and free T4 concentration were quantified.\[[@ref14]\] The value of TSH is 0.27--4.20 mIU/L and free T4 is 12--20 pmol/L, which were calculated from the estimated GFR.\[[@ref15]\]

Serum TSH and free T4 concentration were quantified by electrochemiluminescence immunoassay "ECLIA" using cobas e 411 analyzer (Roche). The reference value of TSH is 0.27--4.20 mIU/L and free T4 is 12--20 pmol/L. The stages of CKD were referenced from kidney disease improving global outcome (KDIGO) guidelines. We defined hypothyroidism as TSH level \>5.5 mIU/L and an FT4 level \<12 pmol/L. Subclinical hypothyroidism was defined as a TSH level \>5.5 mIU/L and normal level of FT4.

Exclusion criteria were subjects younger than 18 years, pregnant women, and subjects receiving antithyroid drugs presumably for hyperthyroidism. In the case of the blood tests not done together, we relied on the closest one.

Results {#sec1-3}
=======

[Table 1](#T1){ref-type="table"} shows that, out of 255 CKD patients in the present study, 166 patients had no hypothyroidism, 43 had subclinical hypothyroidism, and 46 had hypothyroidism. The percentage of hypothyroidism among CKD patients was 34.9%. Out of 24 peritoneal dialyses (PDs) patients in the current study (*P* = 0.03), 7 had subclinical hypothyroidism and another 7 had hypothyroidism. In addition, out of 139 hemodialysis (HD) patients (*P* = 0.02), 20 patients had subclinical hypothyroidism and 18 had hypothyroidism.

###### 

Comparison of different variables in nonhypothyroidism, subclinical hypothyroidism, and hypothyroidism

  Factors      CKD=255   *P*        
  ------------ --------- ----- ---- ----------
  Gender                            0.25
   Male        108       28    24   
   Female      59        14    22   
  DM                                
   No          47        12    19   0.21
   Yes         120       30    27   
  HTN                               
   No          15        5     6    0.67
   Yes         152       37    40   
  IHD                               
   No          129       33    34   0.76
   Yes         38        8     12   
  Transplant                        
   No          145       38    39   0.72
   Yes         22        4     7    
  PD                                
   No          157       35    39   **0.03**
   Yes         10        7     7    
  HD                                **0.02**
   No          66        22    27   
   Yes         101       20    18   
  TOTALS       166       43    46   

[Table 2](#T2){ref-type="table"} shows the mean age of the CKD patients was 64.26 years in nonhypothyroidism, 62.88 years in subclinical hypothyroidism, and 63.13 years in hypothyroidism. The mean creatinine of the CKD patients was 385.40 in nonhypothyroidism, 364.02 in subclinical hypothyroidism, and 383.60 in hypothyroidism. Regarding the normal range 12--20 pmol/L of free T4, the mean T4 of the CKD patients was 15.04 in subclinical hypothyroidism and 12.96 in hypothyroidism, whereas 14.83 in nonhypothyroidism. The normal range of TSH is 0.27--4.20 mIU/L, the mean TSH of the CKD patients was 5.7 in subclinical hypothyroidism and 7.6 in hypothyroidism, whereas 2.04 in nonhypothyroidism. Finally, the mean Estimated Glomerular Filtration Rate eGFR of the CKD patients was 27.65 in nonhypothyroidism, 24.62 in subclinical hypothyroidism, and 31.39 in hypothyroidism.

###### 

Mean of different analysis in nonhypothyroidism, subclinical hypothyroidism, and hypothyroidism

  Factors           Hypothyroidism            
  ----------------- ---------------- -------- --------
  Mean Age          64.26            62.88    63.13
  Mean Creatinine   385.40           364.02   383.60
  Mean T4           14.38            15.04    12.96
  Mean TSH          2.04             5.7      7.6
  Mean eGFR         27.65            24.62    31.39

[Table 3](#T3){ref-type="table"} shows that the majority (67.36%) of CKD patients in the present study were in CKD stage 5, and 45.10% had no hypothyroidism. Only 29 (11.37%) patients in CKD stage 5 had hypothyroidism and 28 (10.89%) patients had subclinical hypothyroidism. [Table 4](#T4){ref-type="table"} shows the frequency of CKD patients after the exclusion of dialysis patients, mainly from CKD stage 5. The prevalence of hypothyroidism among CKD patients was 34.9%, including dialysis patients and 17.66% after exclusion.

###### 

CKD stages in nonhypothyroidism, subclinical hypothyroidism, and hypothyroidism

  CKD stage   Hypothyroidism                 
  ----------- ---------------- ------------- -------------
  1           5 (1.96%)        1 (0.39%)     1 (0.39%)
  2           13 (5.10%)       1 (0.39%)     8 (3.14%)
  3           24 (9.41%)       5 (1.96%)     5 (1.96%)
  4           10 (3.92%)       7 (2.75%)     3 (1.18%)
  5           115 (45.10%)     28 (10.98%)   29 (11.37%)

###### 

CKD stages in nonhypothyroidism, subclinical hypothyroidism, and hypothyroidism after dialysis patient's exclusion

  CKD stage   Hypothyroidism               
  ----------- ---------------- ----------- -----------
  1           5 (1.96%)        1 (0.39%)   1 (0.39%)
  2           13 (5.10%)       1 (0.39%)   8 (3.14%)
  3           24 (9.41%)       5 (1.96%)   5 (1.96%)
  4           10 (3.92%)       7 (2.75%)   2 (2.2%)
  5           4 (4.4%)         1 (1.1%)    4 (4.4%)

[Figure 1](#F1){ref-type="fig"} shows the PTH percentage in CKD patients in the three groups of the present study. PTH was higher in the non hypothyroidism in the no hypothyroidism CKD patients than the hypothyroidism CKD patients. However, PTH was higher in hypothyroidism patients than subclinical hypothyroidism patients.

![Average PTH between three Hypo groups 1 = no, 2 = subclinical, and 3 = Yes data: *F* = 0.87543, num df = 2.00, denom df = 83.98, P-value = 0.4205](JFMPC-8-3313-g001){#F1}

About 6 patients had missing PTH value in the PH and HD groups, and about 4 patients had no PHD value in the HD group.

[Table 5](#T5){ref-type="table"} shows that there were 163 dialysis patients in the current study: 139 HD and 24 PD, whereas 91 CKD patients had no dialysis. T4 was higher in nondialysis patients compared to PD and HD patients (14.87 vs. 13.98 vs. 13.85), respectively. TSH was higher in the dialysis patients, both HD and PD patients compared to nondialysis (9.128 and 6.548 vs. 3.877). PTH was higher also in the dialysis patients, specifically in PD (610.62) than HD patients (374.744) compared to nondialysis patients (184.898). The mean eGFR was higher in nondialysis patients compared to PD and HD patients (48.16 vs. 15.34 vs. 16.73), respectively.

###### 

Comparing groups with HD=1 or PD=1 or (HD and PD=0)

  Group                \# of patients in the group       Mean *t*4
  -------------------- --------------------------------- ---------------
  **Regarding T4:**                                      
  No PD or HD          **91**                            14.8762637
  PD                   **24**                            13.9870833
  HD                   **139**                           13.8537410
                                                         
  **Group**            **\# of patients in the group**   **Mean TSH**
                                                         
  **Regarding TSH:**                                     
                                                         
  No PD or HD          **91**                            3.8776923
  PD                   **24**                            6.5483333
  HD                   **139**                           9.1282734
                                                         
  **Group**            **\# of patients in the group**   **Mean PTH**
                                                         
  **Regarding PTH**                                      
                                                         
  No PD or HD          85                                184.8989412
  PD                   **24**                            610.6208333
  HD                   135                               374.7440000
                                                         
  **Group**            **\# of patients in the group**   **Mean eGFR**
                                                         
  **Regarding eGFR**                                     
                                                         
  No PD or HD          **91**                            48.1673114
  PD                   24                                15.3486903
  HD                   **139**                           16.7356149

Discussion {#sec1-4}
==========

In the present study, out of 255 CKD patients, 166 patients had no hypothyroidism, 43 had subclinical hypothyroidism, and 46 had hypothyroidism. The percentage of hypothyroidism among CKD patients was 34.9%, including dialysis patients and 17.66% after exclusion. The interactions between kidney and thyroid functions are known for years.\[[@ref16][@ref17][@ref18][@ref19]\] Thyroid hormones are essential for the growth and development of the kidney and the maintenance of water and electrolyte homeostasis. From the other point of view, the kidney is involved in the metabolism and elimination of TH. Both hypothyroidism and hyperthyroidism are associated with remarkable alterations in the metabolism of water and electrolyte, as well as in cardiovascular function.\[[@ref20][@ref21]\] All these effects result in changes in water and electrolyte kidney management. Furthermore, the decline of kidney function is accompanied by changes in the synthesis, secretion, metabolism, and elimination of TH. Thyroid dysfunction acquires unique characteristics in those patients with advanced kidney disease.\[[@ref22]\] In the current study, the mean GFR was higher in hypothyroidism (31.39) than in nonhypothyroidism (27.65) or subclinical hypothyroidism (24.62). In addition, GFR was higher in nondialysis patients.

Chonchol *et al.* found that primary subclinical hypothyroidism is a relatively common condition among persons with CKD not requiring chronic dialysis, and it is independently associated with progressively lower estimated GFR in a large cohort of unselected outpatient adults.\[[@ref22]\]

Primary subclinical hypothyroidism is highly prevalent in the general population, especially in the elderly. Anyway, the prevalence of primary subclinical hypothyroidism in persons with CKD not requiring chronic dialysis is not well defined.\[[@ref21]\]

In agreement with our results, Allawi performed a cross-sectional study on 50 patients with CKD, he found that reduced GFR was associated with an increased prevalence of hypothyroidism, with many subclinical cases.\[[@ref23]\]

In on big cohort study, the prevalence of hypothyroidism in CKD patients whose eGFR below 60 around was 22%.\[[@ref2]\] The incidence of hypothyroidism increase with a decrease in GFR in our study but was not statistically significant, unlike another study that showed significant results.\[[@ref4][@ref24]\] We considered the low number of our sample and loss of follow-up and the fact that most of our patients are in CKD stages 4 and 5 and they progress to dialysis need when they are referred to our tertiary hospital. Hence, we consider these factors as a key in changing the association between the fall in GFR and increase prevalence of hypothyroidism when we compare to other studies.

In the current study, PTH was higher in the nonhypothyroid CKD patients and in dialysis patients. However, T4 was higher in nondialysis patients, whereas TSH was higher in dialysis patients.

The thyroid profile changes due to dialysis independent of that due to chronic renal failure. Dialysis also changes the previous serum status of TH in patients with renal failure. In Kannan *et al.* study, not all the patients with chronic renal failure have low T3 and T4. It is estimated that only 58% (29 patients) of patients have thyroid profile abnormality.\[[@ref16]\]

Conclusion {#sec1-5}
==========

The prevalence of hypothyroidism among chronic kidney disease patients was high and increased with the decrease in estimated GFR. Therefore, it is necessary to screen routinely for hypothyroidism in all chronic kidney disease patients.
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